EUVIMEDEUVIMED entdecken
Open Access

Viral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir

Nagarjuna R Cheemarla, Timothy A Watkins, Valia T Mihaylova, Ellen F Foxman iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Nagarjuna R Cheemarla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Oseltamivir, SARS-CoV-2, Antiviral Agents, Coinfection. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mercatus Center, George Mason University, NIH HHS, Gruber Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To gain insight into interactions among respiratory viruses, we modeled influenza A virus (IAV)-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coinfections using differentiated human airway epithelial cultures. Replicating IAV induced a more robust interferon response than SARS-CoV-2 and suppressed SARS-CoV-2 replication in both sequential and simultaneous infections, whereas SARS-CoV-2 did not enhance host cell defense during influenza infection or suppress IAV replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the host antiviral response and restored SARS-CoV-2 replication. These results demonstrate how perturbations in one viral infection can impact its effect on a coinfecting virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OseltamivirSARS-CoV-2Antiviral AgentsCoinfectionInfluenza A virusVirus ReplicationCOVID-19Influenza, HumanViral InterferenceHumansEpithelial CellsRespiratory MucosaCOVID-19 Drug Treatment

Stichwörter der Autor:innen

SARS-CoV-2coinfectioninfluenza virusoseltamivirviral interference

Substanzen

OseltamivirAntiviral Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Ellen F Foxman

Förderung

  • Mercatus Center, George Mason University
  • NIH HHS
  • Gruber Foundation
  • NIAID NIH HHS
  • Yale University
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Cheemarla, N. R., Watkins, T. A., Mihaylova, V. T., & Foxman, E. F. (2024). Viral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad402

Vancouver

Cheemarla NR, Watkins TA, Mihaylova VT, Foxman EF. Viral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad402

BibTeX
@article{Cheemarla2024,
  author = {Cheemarla, Nagarjuna R and Watkins, Timothy A and Mihaylova, Valia T and Foxman, Ellen F},
  title = {Viral Interference During Influenza A–SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad402}
}
Kostenlos starten →